Quadcap Wealth Management, LLC Intellia Therapeutics, Inc. Transaction History
Quadcap Wealth Management, LLC
- $440 Billion
- Q1 2024
A detailed history of Quadcap Wealth Management, LLC transactions in Intellia Therapeutics, Inc. stock. As of the latest transaction made, Quadcap Wealth Management, LLC holds 7,916 shares of NTLA stock, worth $183,255. This represents 0.05% of its overall portfolio holdings.
Number of Shares
7,916
Previous 10,458
24.31%
Holding current value
$183,255
Previous $319 Million
31.7%
% of portfolio
0.05%
Previous 0.08%
Shares
2 transactions
Others Institutions Holding NTLA
# of Institutions
316Shares Held
89.3MCall Options Held
686KPut Options Held
599K-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl11MShares$254 Million2.16% of portfolio
-
Black Rock Inc. New York, NY9.11MShares$211 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA9.09MShares$211 Million0.01% of portfolio
-
State Street Corp Boston, MA4.6MShares$106 Million0.01% of portfolio
-
Deep Track Capital, LP Greenwich, CT4.21MShares$97.5 Million3.83% of portfolio
About Intellia Therapeutics, Inc.
- Ticker NTLA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 76,011,800
- Market Cap $1.76B
- Description
- Intellia Therapeutics, Inc., a genome editing company, focuses on the development of therapeutics. The company's in vivo programs include NTLA-2001, which is in Phase 1 clinical trial for the treatment of transthyretin amyloidosis; and NTLA-2002 for the treatment of hereditary angioedema, as well as other liver-focused programs comprising hemoph...